Incidence of autoimmune thyroiditis in interferon-α treated and untreated patients with chronic hepatitis C virus infection

Neuroendocrinology Letters

Volumn 22, Issue 1, 2001, Pages 39-44

  Rocco, A ^a   Gargano, S ^a   Provenzano, A ^a   Nardone, M R ^a   De Sanctis, G M ^a   Altavilla, N ^a   Chircu, L V ^a   Grimaldi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti thyroid peroxidase autoantibodies; Anti thyroid thyroglobulin autoantibodies; HCV infection; Interferon therapy; Thyroid autoantibodies; Thyroid autoimmunity

Indexed keywords

ALPHA INTERFERON; ALPHAN1 INTERFERON; AUTOANTIBODY; LIOTHYRONINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENDER; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; IMMUNORADIOMETRIC ASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PATIENT SELECTION; PREVALENCE; RADIOIMMUNOASSAY; RISK FACTOR; STATISTICAL ANALYSIS; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 0035110910     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The interferons. Mechanisms of action and clinical applications
2. Interferon action: Effects of mouse α and β-interferons on rosette formation, phagocytosis, and surface-antigen expression of cells of macrophage-type line RAW309Cr 1
3. Elevated interleukin-6 and γ-globulin during interferon therapy for hepatitis B
4. Hepatitis C virus infection, α-interferon therapy and thyroid dysfunction
5. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-α
6. Thyrotropin receptor antibodies following treatment with recombinant α-interferon in patients with hepatitis
7. Thyroid autoimmunity in patients on long term therapy with leukocytes-derived interferon
8. Induction of hyperthyroidism by interferon-α2b
9. Development of thyroid disease during therapy for chronic viral hepatitis with interferon-α
10. Interferon-α induced thyroid dysfunction: Three clinical presentations and a review of the literature
11. Thyroid dysfunction in chronic hepatitis C and following interferon-α2a treatment
12. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon-α therapy
13. Failure to find an association between hepatitis C virus and thyroid autoimmunity
14. Lymphocyte traffic and homing in autoimmune thyroid disorders
15. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: A prospective controlled study
16. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Applications to clinical surveys and tracing infection source
17. Variability of hepatitis C virus
18. Anti-ribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus
19. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
20. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease
21. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
22. Autoimmunity thyroid function in patients with chronic active hepatitis treated with recombinant interferon α-2a
23. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy
24. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activated human T cell clones specific for myelin basic protein
25. High prevalence of autoantibodies to hepatitis-C virus (HCV) in patients with anti-thyroid autoantibodies
26. Diagnostic significance of thyroid microsomal antibodies in randomly selected population
27. Sex hormones, immune responses, and autoimmune disease: Mechanism of sex hormone action
28. The thyroid gland disease
29. Role of the immune system in the control of thyroid function
30. Human autoimmune thyroid disease. Newer views on commonbreakdown in T cell tolerance
31. Thyroid autoimmune disease
32. The spectrum of thyroid disease in a community: The Whickham survey
33. Autoimmune endocrine disease induced by recombinant interferon α therapy for chronic active type C hepatitis
34. Reversibility of thyroid dysfunction induced by recombinant α interferon in chronic hepatitis C
35. Treatment of chronic hepatitis C with alpha-interferon
36. Autoimmunity after α-interferon therapy for malignant carcinoid tumor